| __timestamp | Protagonist Therapeutics, Inc. | Xencor, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 7459000 | 18516000 |
| Thursday, January 1, 2015 | 11831000 | 34140000 |
| Friday, January 1, 2016 | 25705000 | 51872000 |
| Sunday, January 1, 2017 | 46181000 | 71772000 |
| Monday, January 1, 2018 | 59497000 | 97501000 |
| Tuesday, January 1, 2019 | 65003000 | 118590000 |
| Wednesday, January 1, 2020 | 74506000 | 169802000 |
| Friday, January 1, 2021 | 126006000 | 192507000 |
| Saturday, January 1, 2022 | 126215000 | 199563000 |
| Sunday, January 1, 2023 | 120161000 | 253598000 |
Unlocking the unknown
In the competitive world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Protagonist Therapeutics, Inc. and Xencor, Inc. have been at the forefront of this race. Since 2014, Xencor has consistently outpaced Protagonist in R&D investment, with a notable 37% higher spending in 2023. This trend highlights Xencor's aggressive push towards groundbreaking therapies. Meanwhile, Protagonist has shown a steady increase in its R&D budget, peaking in 2022 with a 17-fold increase from 2014. This strategic allocation underscores their dedication to advancing peptide-based therapeutics. As both companies continue to innovate, their R&D investments will likely play a pivotal role in shaping the future of biotech breakthroughs.
R&D Spending Showdown: Johnson & Johnson vs Xencor, Inc.
AbbVie Inc. or Protagonist Therapeutics, Inc.: Who Invests More in Innovation?
United Therapeutics Corporation vs Protagonist Therapeutics, Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Insmed Incorporated and Protagonist Therapeutics, Inc.
Research and Development Expenses Breakdown: Dr. Reddy's Laboratories Limited vs Xencor, Inc.
Analyzing R&D Budgets: Grifols, S.A. vs Xencor, Inc.
Research and Development: Comparing Key Metrics for Alkermes plc and Protagonist Therapeutics, Inc.
Alkermes plc or Xencor, Inc.: Who Invests More in Innovation?
Perrigo Company plc vs Xencor, Inc.: Strategic Focus on R&D Spending
R&D Insights: How Protagonist Therapeutics, Inc. and Ligand Pharmaceuticals Incorporated Allocate Funds
Galapagos NV or Xencor, Inc.: Who Invests More in Innovation?
R&D Spending Showdown: Xencor, Inc. vs MiMedx Group, Inc.